Akers Biosciences Announces Intention to Explore Strategic Alternatives to Maximize Shareholder Value

Akers Biosciences (NASDAQ:AKER) (AIM:AKR.L) a developer of rapid health information technologies, announces that the Board of Directors has initiated a...

Akers Biosciences Hires Medical Device Specialist

Akers Biosciences announced the appointment of a new vice president for sales and distribution of the company.

Akers Biosciences Shares New Board Appointments

Akers Biosciences announced a set of changes to its board of directors.

Akers To Commercialize Medial Test In Puerto Rico

Akers Biosciences is marketing its rapid test for heparin-induced thrombocytopenia to hospitals in Puerto Rico.

Akers To Raise $2 Million With Private Placement

Akers Biosciences (NASDAQ:AKER) plans to raise close to $2 million through a private placement with Joseph Gunnar & Co., LLC.